ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $18.42 Average PT from Brokerages

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price […]

Related Keywords

United States ,Stifel Nicolaus ,Shelly Pinto ,Jason Lettmann ,Forefront Analytics ,Nasdaq ,Sg Americas Securities ,Alx Oncology Holdings Inc ,Hsbc Holdings ,Jp Morgan Private Wealth Advisors ,Oncology Holdings Inc ,Jefferies Financial Group ,Barclays Plc ,Securities Exchange Commission ,Get Free Report ,Financial Group ,Exchange Commission ,Private Wealth Advisors ,Get Free ,Holdings Inc ,